VOYA Investment Management’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-66,880
| Closed | -$3.14M | – | 2638 |
|
|
2025
Q2 | $3.14M | Sell |
66,880
-809,667
| -92% | -$36M | ﹤0.01% | 1128 |
|
|
2025
Q1 | $38.7M | Buy |
876,547
+79,863
| +10% | +$3.68M | 0.04% | 362 |
|
|
2024
Q4 | $28.8M | Buy |
796,684
+67,559
| +9% | +$2.36M | 0.03% | 442 |
|
|
2024
Q3 | $23.4M | Buy |
729,125
+92,027
| +14% | +$3.44M | 0.02% | 504 |
|
|
2024
Q2 | $24M | Buy |
637,098
+52,831
| +9% | +$2.22M | 0.02% | 488 |
|
|
2024
Q1 | $28.8M | Buy |
584,267
+538,747
| +1,184% | +$24.9M | 0.03% | 450 |
|
|
2023
Q4 | $1.66M | Buy |
45,520
+3,559
| +8% | +$92.9K | ﹤0.01% | 1448 |
|
|
2023
Q3 | $970K | Buy |
41,961
+233
| +0.6% | +$6.37K | ﹤0.01% | 1654 |
|
|
2023
Q2 | $1.09M | Buy |
41,728
+9,586
| +30% | +$252K | ﹤0.01% | 1621 |
|
|
2023
Q1 | $827K | Sell |
32,142
-73,705
| -70% | -$2.15M | ﹤0.01% | 1767 |
|
|
2022
Q4 | $2.75M | Hold |
105,847
| – | – | ﹤0.01% | 1209 |
|
|
2022
Q3 | $3.02M | Buy |
105,847
+92,869
| +716% | +$2.66M | ﹤0.01% | 1161 |
|
|
2022
Q2 | $320K | Buy |
12,978
+1,570
| +14% | +$57.4K | ﹤0.01% | 2130 |
|
|
2022
Q1 | $644K | Hold |
11,408
| – | – | ﹤0.01% | 1758 |
|
|
2021
Q4 | $707K | Sell |
11,408
-5
| -0% | -$331 | ﹤0.01% | 1787 |
|
|
2021
Q3 | $724K | Hold |
11,413
| – | – | ﹤0.01% | 1805 |
|
|
2021
Q2 | $941K | Buy |
11,413
+878
| +8% | +$66.7K | ﹤0.01% | 1682 |
|
|
2021
Q1 | $775K | Buy |
10,535
+496
| +5% | +$38.8K | ﹤0.01% | 1751 |
|
|
2020
Q4 | $728K | Buy |
10,039
+2,689
| +37% | +$173K | ﹤0.01% | 1682 |
|
|
2020
Q3 | $350K | Hold |
7,350
| – | – | ﹤0.01% | 1859 |
|
|
2020
Q2 | $309K | Buy |
+7,350
| New | +$262K | ﹤0.01% | 1945 |
|
Other funds holding SWTX
VOYA Investment Management's SWTX Position: Q3 2025 in Review
VOYA Investment Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 66,880 shares — an estimated $3.14M sold.
VOYA Investment Management first reported a position in SWTX in Q2 2020 and held it in 21 quarters. The position peaked at $38.7M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- VOYA Investment Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- VOYA Investment Management sold 66,880 SpringWorks Therapeutics shares in Q3 2025, an estimated $3.14M.
- VOYA Investment Management first reported a position in SpringWorks Therapeutics in Q2 2020 and held it in 21 quarters.
- VOYA Investment Management's SpringWorks Therapeutics position peaked at $38.7M in Q1 2025.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.